Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Oruka Therapeutics, Inc. | 1 131 954 | déclaré | 17 sept. 2025 | tx 6+786 000−160 |
| Viridian Therapeutics, Inc.\DE | 21 000 | déclaré | 01 juil. 2025 | tx 7+136 000 |
| Dianthus Therapeutics, Inc. /DE/ | 0 | déclaré | 27 sept. 2024 | tx 8+149 611−121 003 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 17 sept. 2025 | GRANT_AWARD | Oruka Therapeutics, Inc. | 333 340 | 15.00 USD | |
| 01 juil. 2025 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 21 000 | 0.00 USD | deriv |
| 02 juin 2025 | GRANT_AWARD | Oruka Therapeutics, Inc. | 17 500 | 0.00 USD | deriv |
| 19 nov. 2024 | EXERCISE | Oruka Therapeutics, Inc. | 160 000 | — | |
| 19 nov. 2024 | EXERCISE | Oruka Therapeutics, Inc. | 160 | 0.00 USD | deriv |
| 27 sept. 2024 | OTHER | Dianthus Therapeutics, Inc. /DE/ | 62 146 | 0.00 USD | |
| 11 sept. 2024 | GRANT_AWARD | Oruka Therapeutics, Inc. | 275 000 | 23.00 USD | |
| 11 sept. 2024 | GRANT_AWARD | Oruka Therapeutics, Inc. | 160 | 23000.00 USD | deriv |
| 26 juin 2024 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 21 000 | 0.00 USD | deriv |
| 01 avr. 2024 | OTHER | Dianthus Therapeutics, Inc. /DE/ | 58 857 | — | |
| 01 avr. 2024 | OTHER | Dianthus Therapeutics, Inc. /DE/ | 58 857 | — | |
| 26 sept. 2023 | PURCHASE | Dianthus Therapeutics, Inc. /DE/ | 30 000 | 13.15 USD | |
| 19 sept. 2023 | PURCHASE | Dianthus Therapeutics, Inc. /DE/ | 30 000 | 13.20 USD | |
| 13 sept. 2023 | PURCHASE | Dianthus Therapeutics, Inc. /DE/ | 9 367 | 11.76 USD | |
| 12 sept. 2023 | PURCHASE | Dianthus Therapeutics, Inc. /DE/ | 14 887 | 10.85 USD | |
| 11 sept. 2023 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 6 500 | 0.00 USD | deriv |
| 14 juin 2023 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 20 000 | 0.00 USD | deriv |
| 08 juin 2022 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 12 500 | 0.00 USD | deriv |
| 03 juin 2021 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 12 500 | 0.00 USD | deriv |
| 04 févr. 2021 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 25 000 | 0.00 USD | deriv |
| 27 oct. 2020 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 24 000 | 0.00 USD | deriv |